Our Leadership

Our company is led by a passionate team of professionals with deep experience in the pharmaceutical industry and a proven track record of success in developing and commercializing novel treatments for patients.

Close Button
Photo of JEFFREY M. DAYNO, M.D.

JEFFREY M. DAYNO, M.D.

Interim Chief Executive Officer and Chief Medical Officer

Jeffrey M. Dayno, M.D., is Chief Medical Officer for Harmony Biosciences. A nationally recognized expert in neuroscience, Dr. Dayno is currently responsible for managing research, development and medical and regulatory affairs for Harmony Biosciences.

He is a neurologist with 10 years experience in clinical/academic medicine followed by over 20 years experience in leadership roles at Merck & Co., Cephalon, and ViroPharma, building and leading clinical, regulatory and medical affairs teams toward multiple NDA approvals and medical support of successful product launches.

Dr. Dayno has served as Principal Investigator on numerous clinical trials and published and lectured extensively on various topics in the field of Neurology, with a focus on stroke, sleep disorders, pain and migraine. He has also served as a peer reviewer for several scientific neurology journals.

Dr. Dayno earned his medical degree from Temple University School of Medicine, did his residency training in Neurology at Temple University Hospital, and completed a fellowship in Stroke and Cerebrovascular Disorders in the Department of Neurology at Henry Ford Hospital.

Jeffrey Dayno, MD is Chief Medical Officer of Harmony Biosciences

JEFFREY M. DAYNO, M.D.

Read Bio
Mr. Dierks is Chief Commercial Officer for Harmony Biosciences. 

JEFFREY DIERKS, MBA

Read Bio
Mr. Kapadia is Chief Financial Officer and has over 25 years of life sciences industry experience across multiple therapeutic areas and has provided strategic financial oversight and guidance to companies both in the United States and Europe.

SANDIP KAPADIA, CPA, MBA

Read Bio
Mr. Ulrich serves as General Counsel at Harmony Biosciences

CHRISTIAN ULRICH

Read Bio
Cate McCanless is the Head of Corporate Affairs and Public Policy for Harmony Biosciences.

CATE MCCANLESS

Read Bio
Mr. Serafin is the Chief Strategy Officer at Harmony Biosciences and is responsible for leading the company’s corporate strategy, business and corporate development initiatives, and alliance management efforts, including the expansion of the company’s pipeline through the acquisition and licensing of novel rare disease therapies for patients with high, unmet needs.

ANDREW SERAFIN, JD, MBA

Read Bio
Ms. Glover is Chief Compliance Officer at Harmony Biosciences where she is responsible for overseeing the strategic direction and the operational excellence of Harmony’s Corporate Compliance Program.

TRICIA GLOVER

Read Bio
Ms. Murphy is the Head of Human Resources at Harmony Biosciences.

AUDREY MURPHY

Read Bio
Mr. Bradshaw is the Head of Technical Operations at Harmony Biosciences and is responsible for leading the company’s manufacturing, chemistry and controls (CMC) development and quality assurance functions, including manufacturing and supply management strategies for the company’s commercial drug products.

DAVID BRADSHAW

Read Bio
Mr. Knouft is currently responsible for leading and ensuring strategic alignment for all market access and commercial field sales activities. 

DAVID KNOUFT

Read Bio
Ms. Goldbach is the Head of Facilities Operations and Executive Administration for Harmony Biosciences.

SHARON GOLDBACH

Read Bio

Board of Directors

Jeff Aronin is chairman and chief executive officer of Paragon Biosciences

Jeff Aronin

Read Bio

Antonio Gracias
Managing Partner/
Chief Investment Officer
Valor Equity

Mark Graf
Private Investor
Former Chief Financial Officer
Discover Financial Services

Jack Nielsen
Managing Director
Vivo Capital Fund VIII, L.P./
Vivo Capital Surplus Fund VIII, L.P.

Juan Sabater
Partner
Valor Equity

Gary Sender
Former Chief Financial Officer, Nabriva plc
Independent Board Member & Consultant

Linda Szyper
Former Chief Operating Officer
McCann Health

Dr. Andreas Wicki
CEO
HBM Healthcare Investments (Cayman) Ltd